Here is this week’s Deal Report for private equity and venture capital activity for US-based PE and VC firms and portfolio companies, brought to you by Scherzer International.

PE and VC Firms Fundraising Location Amount Description
March Capital Santa Monica, CA $60M Gaming-focused fund

Private Equity Investors Company  Amount Description
KKR Citation Group Undisclosed British provider of subscription-based HR/employment law and health/safety services to SMEs
Brookfield Infrastructure Cheniere Energy $7B Houston, TX-based liquefied natural gas producer
MidOcean Partners Music Reports Undisclosed Woodland Hills, CA-based provider of music rights data and management services
Accel-KKR Navtor Undisclosed Norwegian provider of navigational software for the maritime industry
Kohlberg & Co., Mubadala Investment Co. PCI Pharma Services Undisclosed Philadelphia, PA-based provider of pharma supply chain solutions
Mill Rock Capital Trojan Lithograph Undisclosed Renton, WA-based maker of folding cartons and single-face laminate packaging
TPG, Warburg Pincus Visma Undisclosed Norwegian enterprise software company

Venture Capital Investors Company  Amount Description
RA Capital Management, Lilly Asia Ventures, Boxer Capital, HBM Healthcare Investments, Qiming Venture Partners Connect Biopharma $115M China and San Diego-based developer of therapies for autoimmune diseases and inflammation
Stripes Group, Tiger Global Management Dataiku $100M New York-based Enterprise AI and machine learning platform
Lightspeed Venture Partners, American Express Ventures Finix $30M San Francisco-based payments infrastructure platform
Bain Capital Life Sciences, Perceptive Advisors, Fidelity, Janus Henderson, Farallon Capital Management, Rock Springs Capital, Cormorant Asset Management, EcoR1, Catalio Capital, the Colorectal Cancer Alliance, RA Capital Management, T. Rowe Price, BrightEdge Ventures, Sands Capital, Andreessen Horowitz, DCVC, GV, Kaiser Permanente Ventures, Novartis, Polaris Partners, Roche Venture Fund, Soleus Capital, Section 32 Freenome $270M South San Francisco-based developer of early colorectal cancer testing via blood draw
Bill Gates Kymeta $85.2M Redmond, WA-based developer of satellite communication antennas and systems
Addition, Adams Street Partners, Howard Schultz, Casdin Capital, Glynn Capital, Greylock Partners, IVP, Meritech Capital Partners, Providence Ventures, Tenaya Capital Lyra Health $110M Burlingame, CA-based provider of mental health care benefits for employers
GMAG Holdings Motiv Power Systems $15M Foster City, CA-based maker of electric truck chasses
Insight Partners, Tiger Global, Slack Fund, World Innovation Lab, Gradient Ventures Mural $118M San Francisco-based provider of digital workspaces for enterprise visual collaboration
Bayer One Drop $34.7M New York-based provider of digital solutions for people living with diabetes
HLM Venture Partners, Commonfund, Vivo Capital, Toba Capital, Transformation Capital, SVB PatientPop $50M Santa Monica, CA-based online marketing platform for medical practice
Bain Capital Ventures, TCV,  Francisco Partners, Dell Technologies Capital, Goldman Sachs, Viola Ventures Redis Labs $100M Mountain View, CA-based open source database
KKR, Ten Eleven Ventures, Brian Murphy ReliaQuest $300M Tampa, FL-based enterprise cybersecurity managed service and intelligence platform
Sapphire Ventures, Insight Partners Restream $50M Austin, TX-based startup focused on streaming to multiple platform
Bessemer Venture Partners, Index Ventures,, I2BF Shopmonkey $25M San Jose, CA-based SaaS startup focused on auto repair shops
Sorenson Venturesled, Citi Ventures, Wells Fargo, MVB Financial, Commerce Ventures, Scale Venture Partners, Flint Capital Socore $35M New York-based identity verification startup
St. Baker family office Songtradr $30M Santa Monica, CA-based music licensing platform
Comcast Ventures, 01 Advisors, M12, Atlassian, ServiceNow, Accel, Lightspeed Venture Partners, Harmony Venture Partners Split $33M Redwood City, CA-based feature delivery platform
Bayer, Northpond Ventures, Oceanpine Capital, Viva Biotech Holdings, Bloom Burton & Co., Centre for Commercialization of Cancer Triumvira Immunologics $55M Austin, TX-based cancer therapies developer